Impact of COVID-19 in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Possible Role of the Association to Anti-CD20 Antibody? a Multicentre Seifem Study

被引：0

作者：

Autore, Francesco ^{[1
]}

Visentin, Andrea ^{[2
]}

Deodato, Marina ^{[3
]}

Vitale, Candida ^{[4
]}

Galli, Eugenio ^{[1
]}

Fresa, Alberto ^{[1
]}

Fazzi, Rita ^{[5
]}

Sanna, Alessandro ^{[6
]}

Olivieri, Jacopo ^{[7
]}

Scortechini, Ilaria ^{[8
]}

Del Principe, Maria Ilaria ^{[9
]}

Sportoletti, Paolo ^{[10
]}

Schiattone, Luana ^{[11
]}

Maschio, Nilla ^{[12
]}

Facchinelli, Davide ^{[13
]}

Coscia, Marta ^{[14
]}

Tedeschi, Alessandra ^{[15
]}

Trentin, Livio ^{[16
]}

Innocenti, Idanna ^{[17
]}

Candoni, Anna ^{[18
]}

Busca, Alessandro ^{[19
]}

Pagano, Livio ^{[20
]}

Laurenti, Luca ^{[21
]}

机构：

[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Diagnost Immagini Radioterapia & Onc, Rome, Italy

[2] Univ Padua, Dept Med, Hematol Unit, Padua, Italy

[3] ASST Grande Osped Metropolitano Niguarda, Dept Hematol, Milan, Italy

[4] AOU Citta Salute & Sci Torino, Turin, Italy

[5] Azienda Osped Univ Pisana, Pisa, Italy

[6] AOU Careggi, Hematol, Florence, Italy

[7] Azienda Sanitaria Univ Integrata Udine, Ctr Trapianti & Terapie Cellulari Carlo Melzi, Clin Ematol, Udine, Italy

[8] Azienda Osped Univ Marche, Ancona, Italy

[9] Univ Tor Vergata, Dept Biomed & Prevent, Hematol, Rome, Italy

[10] Univ Perugia, Ctr Ric Ematooncol CREO, Dipartimento Med & Chirurg, Perugia, Italy

[11] Presidio Osped Santo Spirito, UOSD Ctr Diagnosi & Terapia Linfomi, Pescara, Italy

[12] IRCCS, Veneto Inst Oncol IOV, Dept Oncol, Onco Hematol, Padua, Italy

[13] Osped San Bortolo, Vicenza, Italy

[14] AOU Citta Salute & Sci Torino, Turin, Italy

[15] ASST Grande Osped Metropolitano Niguarda, Milan, Italy

[16] Univ Padua, Dept Med, Hematol Unit, Padua, Italy

[17] Fdn Univ Policlin A Gemelli Roma, Rome, Italy

[18] Univ Modena & Reggio Emilia, Dipartimento Sci Med & Chirurg Materno Infantil &, Udine, Italy

[19] AOU Citta Salute & Sci Torino Torino, SSCVD Trapianto Cellule Staminali, Turin, Italy

[20] Fdn Policlin Univ Agostino Gemelli IRCCS, Hematol Unit, Rome, Italy

[21] Fdn Univ Policlin A Gemelli Roma, Div Hematol, Rome, Italy

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180955

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] Impact of COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: a possible role of the association to anti-CD20 antibody? A multicentre SEIFEM study
Autore, Francesco
Visentin, Andrea
Deodato, Marina
Vitale, Candida
Galli, Eugenio
Fresa, Alberto
Fazzi, Rita
Sanna, Alessandro
Olivieri, Jacopo
Scortechini, Ilaria
del Principe, Maria Ilaria
Sportoletti, Paolo
Schiattone, Luana
Maschio, Nilla
Facchinelli, Davide
Coscia, Marta
Tedeschi, Alessandra
Trentin, Livio
Innocenti, Idanna
Candoni, Anna
Busca, Alessandro
Pagano, Livio
Laurenti, Luca
LEUKEMIA & LYMPHOMA, 2023, 64 : S27 - S28
[2] COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
Autore, Francesco
Visentin, Andrea
Deodato, Marina
Vitale, Candida
Galli, Eugenio
Fresa, Alberto
Fazzi, Rita
Sanna, Alessandro
Olivieri, Jacopo
Scortechini, Ilaria
Principe, Maria Ilaria Del
Sportoletti, Paolo
Innocenti, Idanna
Coscia, Marta
Tedeschi, Alessandra
Trentin, Livio
Candoni, Anna
Busca, Alessandro
Pagano, Livio
Laurenti, Luca
BLOOD ADVANCES, 2025, 9 (01) : 162 - 165
[3] Omission of Anti-CD20 Antibody in Chronic Lymphocytic Leukemia during COVID-19 Pandemic: Twelve Month Course of Venetoclax Is a Safe and Effective Alternative Regimen
Shahab, Aarib M.
Yunus, Saadia
BLOOD, 2023, 142
[4] Impact of Anti-CD20 Antibodies on the Incidence of Secondary Cancers in Patients Treated for Chronic Lymphocytic Leukemia
Guidez, Stephanie
Demarquette, Helene
Nudel, Morgane
Le Grand, Charline
Boyle, Eileen
Herbaux, Charles
Facon, Thierry
Cazin, Bruno
Morschhauser, Franck
BLOOD, 2015, 126 (23)
[5] IMPACT OF ANTI-CD20 ANTIBODIES ON THE INCIDENCE OF SECONDARY CANCERS IN PATIENTS TREATED FOR CHRONIC LYMPHOCYTIC LEUKEMIA
Guidez, S.
Demarquette, H.
Nudel, M.
Le Grand, C.
Herbaux, C.
Facon, T.
Cazin, B.
Morschhauser, F.
HAEMATOLOGICA, 2016, 101 : 443 - 444
[6] Chronic Obstructive Pulmonary Disease and Previous Infections Have Impact on Infectious Complications in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Multicentre Seifem Study
Autore, Francesco
Visentin, Andrea
Deodato, Marina
Vitale, Candida
Galli, Eugenio
Fresa, Alberto
Fazzi, Rita
Sanna, Alessandro
Olivieri, Jacopo
Scortechini, Ilaria
Del Principe, Maria Ilaria
Sportoletti, Paolo
Schiattone, Luana
Maschio, Nilla
Facchinelli, Davide
Coscia, Marta
Tedeschi, Alessandra
Trentin, Livio
Innocenti, Idanna
Candoni, Anna
Busca, Alessandro
Pagano, Livio
Laurenti, Luca
BLOOD, 2023, 142
[7] Chronic obstructive pulmonary disease and previous infections have impact on infectious complications in patients with chronic lymphocytic leukemia treated with venetoclax: a multicentre SEIFEM study.
Autore, Francesco
Visentin, Andrea
Deodato, Marina
Vitale, Candida
Galli, Eugenio
Fresa, Alberto
Fazzi, Rita
Sanna, Alessandro
Olivieri, Jacopo
Scortechini, Ilaria
del Principe, Maria Ilaria
Sportoletti, Paolo
Schiattone, Luana
Maschio, Nilla
Facchinelli, Davide
Coscia, Marta
Tedeschi, Alessandra
Trentin, Livio
Innocenti, Idanna
Candoni, Anna
Busca, Alessandro
Pagano, Livio
Laurenti, Luca
LEUKEMIA & LYMPHOMA, 2023, 64 : S60 - S61
[8] Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Chuda, Ravindra R.
Vishnu, Prakash
Aboulafia, David
CURRENT DRUG THERAPY, 2012, 7 (04) : 281 - 289
[9] Treatment of chronic lymphocytic leukemia (CLL)with the anti-CD20 antibody rituximab.
Emmerich, B
Huhn, D
Peschel, C
Wilhelm, M
von Schilling, C
Bentz, M
Hallek, M
Knauf, B
Kuse, R
Ho, AD
BLOOD, 1999, 94 (10) : 309B - 309B
[10] Risk factors for hypogammaglobulinemia in chronic lymphocytic leukemia patients treated with anti-CD20 monoclonal antibody-based therapies
Caitlin M. McNulty
Emasenyie A. Isikwei
Pragya Shrestha
Melissa R. Snyder
Brian F. Kabat
Kari G. Rabe
Susan L. Slager
Sameer A. Parikh
Avni Y. Joshi
Journal of Hematopathology, 2020, 13 : 221 - 229

← 1 2 3 4 5 →